Harvard Bioscience Inc (HBIO) earnings
Quarterly results of Harvard Bioscience Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Harvard Bioscience Inc was expected to report around November 5, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Harvard Bioscience Inc reported revenue of $22.7M (+11.1% on the same quarter a year earlier) and a net loss of $2.9M.
Diluted earnings per share were -$0.64.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $22.7M | +11.1% | -$2.9M | -$0.64 |
| Q1 FY2026 | $20.8M | -4.7% | -$3.4M | -$0.77 |
| Q4 FY2025 | $23.7M | -3.3% | -$2.8M | - |
| Q3 FY2025 | $20.6M | -6.3% | -$1.2M | -$0.03 |
| Q2 FY2025 | $20.5M | - | -$2.3M | -$0.52 |
| Q1 FY2025 | $21.8M | - | -$50.3M | -$11.42 |
| Q4 FY2024 | $24.6M | - | $18K | - |
| Q3 FY2024 | $22M | - | -$4.8M | -$0.11 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
When is Harvard Bioscience Inc's next earnings date?
Harvard Bioscience Inc was expected to report around November 5, 2026; nothing is on file with the SEC yet.
What were Harvard Bioscience Inc's latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Harvard Bioscience Inc reported revenue of $22.7M and a net loss of $2.9M. The figures come from its filing with the SEC.
Is Harvard Bioscience Inc's revenue growing?
Revenue in Q2 FY2026 was $22.7M, up 11.1% from $20.5M in the same quarter a year earlier.
Get an email when HBIO reports
Follow HBIO and we email you its next results the day they are filed, with the numbers explained.